16 June 2021 - New drugs and vaccines likely to increase life expectancy, quality of life and save money, so we should reduce approval delays as much as possible.
The past year has shown us beyond the shadow of a doubt that human ingenuity is a match for the greatest of challenges.
The rapid development and mass production of several COVID-19 vaccines are proof of our remarkable capacity for innovation.